Skye Bioscience
SKYE
SKYE
39 hedge funds and large institutions have $9.91M invested in Skye Bioscience in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
22% less funds holding
Funds holding: 50 → 39 (-11)
36% less call options, than puts
Call options by funds: $25K | Put options by funds: $39K
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Holders
39
Holding in Top 10
1
Calls
$25K
Puts
$39K
Top Buyers
| 1 | +$163K | |
| 2 | +$102K | |
| 3 | +$54.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$26.5K |
| 5 |
BlackRock
New York
|
+$3.5K |
Top Sellers
| 1 | -$99.6K | |
| 2 | -$70K | |
| 3 | -$21.2K | |
| 4 |
HF
HRT Financial
New York
|
-$20K |
| 5 |
Jane Street
New York
|
-$18.5K |
